Pulmonary Fibrosis
Show Only Open Trials
1.
A Phase 2, Randomized, Double-Blind, Placebo-Controlled, Multi-Center Study to Assess the Efficacy and Safety of GS-6624 in Subjects with Idiopathic Pulmonary Fibrosis (RAINIER)
- Study Status: Open to Enrollment
- Sponsor: Gilead
- Disease Status and/or Stage: Idiopathic Pulmonary Fibrosis (IPF)
2.
PANTHER Study (Prednisone, Azathioprine, and N-acetylcysteine: A Study That Evaluates Response in IPF)
- Study Status: Closed to Enrollment
- Sponsor: IPFnet/NIH
- Disease Status and/or Stage: Idiopathic Pulmonary Fibrosis (IPF)
3.
ACE-IPF Study (AntiCoagulant Effectiveness in Idiopathic Pulmonary Fibrosis)
- Study Status: Closed to Enrollment
- Sponsor: IPFnet/NIH
- Disease Status and/or Stage: Idiopathic Pulmonary Fibrosis (IPF)
